Linkage disequilibrium between tnf-α-308 G/A promoter and histocompatibility leukocyte antigen alleles in han-nationality lung transplant recipients from eastern china

Experimental and Clinical Transplantation

Volumn 11, Issue 3, 2013, Pages 264-269

  Huijun, Mu ^a   Ji, Zhang ^a   Ping, Xie ^a   Jingyu, Chen ^a   Bin, Zhang ^a  

^a WUXI PEOPLE S HOSPITAL AFFILIATED TO NANJING MEDICAL UNIVERSITY   (China)

Author keywords

HLA; Linkage disequilibrium; Lung transplant; Rejection; TNF

Indexed keywords

HLA A ANTIGEN; HLA ANTIGEN; HLA B ANTIGEN; HLA DRB1 ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ACUTE GRAFT REJECTION; ALLELE; ARTICLE; CHINA; CONTROLLED STUDY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC CORRELATION; GENOTYPE; GRAFT RECIPIENT; HAPLOTYPE; HUMAN; INCIDENCE; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GRAFT REJECTION; HLA ANTIGENS; HLA-A ANTIGENS; HLA-B ANTIGENS; HLA-DRB1 CHAINS; HUMANS; LINKAGE DISEQUILIBRIUM; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84874741919     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: 10.6002/ect.2012.0099     Document Type: Article

References (40)

1. Wohlschläger J, Sommerwerck U, Jonigk D, Rische J, Baba HA, Müller KM. Lung transplantation and rejection. Basic principles, clinical aspects and histomorphology [in German]. Pathologe. 2011;32(2):104-112.
2. Gomez C, Reynaud-Gaubert M. Long-term outcome of lung transplantation [in French]. Rev Pneumol Clin. 2010;67(1):64-73.
3. Mathur A, Baz M, Staples ED, et al. Cytokine profile after lung transplantation: correlation with allograft injury. Ann Thorac Surg. 2006;81(5):1844-1849; discussion 1849-1850.
4. Pu J, Zeng WY. Relationship among TNF-alpha gene promoter - 308 site polymorphism, the levels of maternal serum TNF-alpha, and the mRNA expression placental TNF-alpha in preterm labor [in Chinese]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2009;40(1): 77-80.
5. Tinckam K, Rush D, Hutchinson I, et al. The relative importance of cytokine gene polymorphisms in the development of early and late acute rejection and six-month renal allograft pathology. Transplantation. 2005;79(7):836-841.
6. Azzawi M, Hasleton PS, Turner DM, et al. Tumor necrosis factor-alpha gene polymorphism and death due to acute cellular rejection in a subgroup of heart transplant recipients. Hum Immunol. 2001;62(2):140-142.
7. Ternstrom L, Jeppsson A, Ricksten A, Nilsson F. Tumor necrosis factor gene polymorphism and cardiac allograft vasculopathy. J Heart Lung Transplant. 2005;24(4):433-438.
8. Colvin RB. Cellular and molecular mechanisms of allograft rejection. Annu Rev Med. 1990;41:361-375.
9. Opelz G, Döhler B. Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report. Transplantation. 2010;90(3):292-297.
10. Slatkin M. Linkage disequilibrium--understanding the evolutionary past and mapping the medical future. Nat Rev Genet. 2008;9(6):477-485.
11. Valente FP, Tan C, Phipps M, et al. TNF block haplotypes associated with conserved MHC haplotypes in European, Asian and Australian Aboriginal donors. Tissue Antigens. 2009;74(1):57-61.
12. Ovsyannikova IG, Vierkant RA, Pankratz VS, Jacobson RM, Poland GA. Extended LTA, TNF, LST1 and HLA gene haplotypes and their association with rubella vaccine-induced immunity. PLoS One. 2010;5(7):e11806.
13. Kumar R, Goswami R, Agarwal S, Israni N, Singh SK, Rani R. Association and interaction of the TNF-alpha gene with other proand anti-inflammatory cytokine genes and HLA genes in patients with type 1 diabetes from North India. Tissue Antigens. 2007;69(6):557-567.
14. Lu MC, Yang KL, Tung CH, et al. Higher LPS-stimulated TNF-alpha mRNA levels in peripheral blood mononuclear cells from Chinese ankylosing spondylitis patients with -308G/A polymorphism in promoter region of tumor necrosis factor: association with distinct A33/B58/Cw10 haplotypes. Rheumatol Int. 2008;29(2):189-195.
15. Stewart S, Fishbein MC, Snell GI, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant. 2007;26(12):1229-1242.
16. Chen Y, Cicciarelli J, Pravica V, Hutchinson IV. Long-range linkage on chromosome 6p of VEGF, FKBP5, HLA and TNF alleles associated with transplant rejection. Mol Immunol. 2009;47(1):96-100.
17. Magalhães RF, Biral AC, Pancoto JA, et al. Human leukocyte antigen (HLA) and single nucleotide polymorphisms (SNPs) tumor necrosis factor (TNF)-alpha -238 and -308 as genetic markers of susceptibility to psoriasis and severity of the disease in a long-term follow-up Brazilian study. Int J Dermatol. 2010;49(10):1133-1140.
18. Hajeer AH, Hutchinson IV. Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol. 2001;62(11):1191-1199.
19. Schotte H, Willeke P, Tidow N, et al. Extended haplotype analysis reveals an association of TNF polymorphisms with susceptibility to systemic lupus erythematosus beyond HLA-DR3. Scand J Rheumatol. 2005;34(2):114-121.
20. Medcraft J, Hitman GA, Sachs JA, Whichelow CE, Raafat I, Moore RH. Autoimmune renal disease and tumour necrosis factor beta gene polymorphism. Clin Nephrol. 1993;40(2):63-68.
21. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med. 1993;177(2):557-560.
22. Price P, Bolitho P, Jaye A, et al. A Gambian TNF haplotype matches the European HLA-A1,B8,DR3 and Chinese HLA-A33, B58, DR3 haplotypes. Tissue Antigens. 2003;62(1):72-75.
23. Witt CS, Price P, Kaur G, et al. Common HLA-B8-DR3 haplotype in Northern India is different from that found in Europe. Tissue Antigens. 2002;60(6):474-480.
24. Kuffner T, Whitworth W, Jairam M, McNicholl J. HLA class II and TNF genes in African Americans from the Southeastern United States: regional differences in allele frequencies. Hum Immunol. 2003;64(6):639-647.
25. Yamamoto-Furusho JK, Uscanga LF, Vargas-Alarcón G, Rodríguez-Pérez JM, Zuñiga J, Granados J. Polymorphisms in the promoter region of tumor necrosis factor alpha (TNF-alpha) and the HLA-DRB1 locus in Mexican mestizo patients with ulcerative colitis. Immunol Lett. 2004;95(1):31-35.
26. Baena A, Leung JY, Sullivan AD, et al. TNF-alpha promoter single nucleotide polymorphisms are markers of human ancestry. Genes Immun. 2002;3(8):482-487.
27. McGuire W, Hill AV, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 1994;371(6497):508-510.
28. Richardson A, Sisay-Joof F, Ackerman H, et al. Nucleotide diversity of the TNF gene region in an African village. Genes Immun. 2001;2(6):343-348.
29. Cheong KY, Allcock RJ, Eerligh P, et al. Localization of central MHC genes influencing type I diabetes. Hum Immunol. 2001;62(12):1363-1370.
30. Stirnadel HA, Stöckle M, Felger I, Smith T, Tanner M, Beck HP. Malaria infection and morbidity in infants in relation to genetic polymorphisms in Tanzania. Trop Med Int Health. 1999;4(3):187-193.
31. Louis E, Franchimont D, Piron A, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol. 1998;113(3):401-406.
32. Bittar MN, Carey JA, Barnard JB, et al. Tumor necrosis factor alpha influences the inflammatory response after coronary surgery. Ann Thorac Surg. 2006;81(1):132-137.
33. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A. 1997;94(7):3195-3199.
34. Alakulppi NS, Kyllönen LE, Jäntti VT, et al. Cytokine gene polymorphisms and risks of acute rejection and delayed graft function after kidney transplantation. Transplantation. 2004;78(10):1422-1428.
35. Pawlik A, Domanski L, Rozanski J, et al. IL-2 and TNF-alpha promoter polymorphisms in patients with acute kidney graft rejection. Transplant Proc. 2005;37(5):2041-2043.
36. Kocierz M, Siekiera U, Kolonko A, et al. -174G/C interleukin-6 gene polymorphism and the risk of transplanted kidney failure or graft loss during a 5-year follow-up period. Tissue Antigens. 2011;77(4):283-290.
37. Omrani MD, Mokhtari MR, Bagheri M, Ahmadpoor P. Association of interleukin-10, interferon-gamma, transforming growth factor-beta, and tumor necrosis factor-alpha gene polymorphisms with long-term kidney allograft survival. Iran J Kidney Dis. 2010;4(2):141-146.
38. Malkki M, Gooley TA, Horowitz MM, et al; International Histocompatibility Working Group in Transplantation. Mapping MHCresident transplantation determinants. Biol Blood Marrow Transplant. 2007;13(8):986-995.
39. Malkki M, Gooley T, Horowitz M, Petersdorf EW; IHWG HCT Component. MHC class I, II, and III microsatellite marker matching and survival in unrelated donor hematopoietic cell transplantation. Tissue Antigens. 2007;69 (suppl 1):46-49.
40. de Vlam K, Gottlieb AB, Fitzgerald O. Biological biomarkers in psoriatic disease. A review. J Rheumatol. 2008;35(7):1443-1448.